INS and Alzheimer disease: 2-deoxy-d-glucose (2DG) and methylglioxal (MG) are metabolites that may compromise energy efficiency of the neuronal cell causing impaired glycolysis and, in that, mimicking metabolic dysfunction of neurons in AD and other conditions of brain insulin resistance.